MediciNova Historical Balance Sheet
MNOV Stock | USD 2.13 0.13 6.50% |
Trend analysis of MediciNova balance sheet accounts such as Common Stock Shares Outstanding of 24.6 M provides information on MediciNova's total assets, liabilities, and equity, which is the actual value of MediciNova to its prevalent stockholders. By breaking down trends over time using MediciNova balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining MediciNova latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether MediciNova is a good buy for the upcoming year.
MediciNova |
About MediciNova Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of MediciNova at a specified time, usually calculated after every quarter, six months, or one year. MediciNova Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of MediciNova and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which MediciNova currently owns. An asset can also be divided into two categories, current and non-current.
MediciNova Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of MediciNova assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in MediciNova books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most accounts from MediciNova's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into MediciNova current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MediciNova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.At this time, MediciNova's Total Current Liabilities is fairly stable compared to the past year. Property Plant And Equipment Net is likely to climb to about 652.3 K in 2024, whereas Total Stockholder Equity is likely to drop slightly above 50.9 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Total Stockholder Equity | 83.7M | 70.2M | 62.4M | 50.9M | Total Assets | 87.4M | 74.2M | 66.3M | 62.3M |
MediciNova balance sheet Correlations
Click cells to compare fundamentals
MediciNova Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MediciNova balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 79.2M | 75.4M | 87.4M | 74.2M | 66.3M | 62.3M | |
Total Stockholder Equity | 74.9M | 71.3M | 83.7M | 70.2M | 62.4M | 50.9M | |
Retained Earnings | (369.1M) | (382.9M) | (393.1M) | (407.1M) | (415.7M) | (394.9M) | |
Other Assets | 59.8K | 5.0M | 97.9M | 92.8K | 106.7K | 101.4K | |
Common Stock Shares Outstanding | 43.2M | 44.4M | 48.6M | 49.0M | 49.0M | 24.6M | |
Liabilities And Stockholders Equity | 79.2M | 75.4M | 87.4M | 74.2M | 66.3M | 62.3M | |
Other Stockholder Equity | 444.0M | 454.3M | 476.8M | 477.4M | 478.1M | 331.0M | |
Total Liab | 4.3M | 4.1M | 3.7M | 3.9M | 3.9M | 3.7M | |
Other Current Liab | 1.8M | 1.6M | 2.3M | 2.6M | 2.1M | 1.6M | |
Total Current Liabilities | 2.2M | 2.2M | 2.8M | 3.2M | 3.3M | 4.5M | |
Property Plant And Equipment Net | 40.6K | 55.7K | 881.8K | 674.8K | 621.2K | 652.3K | |
Net Debt | (63.4M) | (59.9M) | (71.3M) | (18.3M) | (50.8M) | (48.2M) | |
Accounts Payable | 451.3K | 616.6K | 402.7K | 424.6K | 1.0M | 722.3K | |
Cash | 63.8M | 60.0M | 71.4M | 18.5M | 51.0M | 32.1M | |
Non Current Assets Total | 14.9M | 14.7M | 15.4M | 15.2M | 15.1M | 15.4M | |
Cash And Short Term Investments | 63.8M | 60.0M | 71.4M | 58.5M | 51.0M | 35.9M | |
Common Stock Total Equity | 43.9K | 45.0K | 49.0K | 49.0K | 56.4K | 31.3K | |
Non Current Liabilities Total | 2.1M | 1.9M | 896.5K | 725.4K | 612.5K | 581.8K | |
Other Current Assets | 511.9K | 680.2K | 578.0K | 499.4K | 174.9K | 166.2K | |
Property Plant And Equipment Gross | 40.6K | 55.7K | 1.3M | 1.1M | 1.1M | 1.1M | |
Total Current Assets | 64.3M | 60.7M | 72.0M | 59.0M | 51.2M | 38.1M | |
Common Stock | 43.9K | 45.0K | 49.0K | 49.0K | 56.4K | 32.4K | |
Other Liab | 1.9M | 1.9M | 1.9M | 201.8K | 232.1K | 220.5K | |
Non Currrent Assets Other | 459.8K | 246.2K | 115.5K | 92.8K | 74.2K | 70.4K | |
Accumulated Other Comprehensive Income | (92.7K) | (88.2K) | (98.9K) | (115.3K) | (118.1K) | (124.0K) | |
Property Plant Equipment | 40.6K | 55.7K | 57.6K | 45.3K | 40.7K | 38.7K | |
Short Long Term Debt Total | 399.3K | 184.8K | 132.0K | 157.5K | 215.9K | 205.1K | |
Net Tangible Assets | 65.3M | 61.7M | 74.1M | 60.6M | 69.7M | 41.2M | |
Retained Earnings Total Equity | (369.1M) | (382.9M) | (393.1M) | (407.1M) | (366.4M) | (384.7M) | |
Capital Surpluse | 444.0M | 454.3M | 476.8M | 477.4M | 549.1M | 427.3M | |
Net Invested Capital | 74.9M | 71.3M | 83.7M | 70.2M | 62.4M | 74.5M | |
Net Working Capital | 62.1M | 58.5M | 69.2M | 55.8M | 47.9M | 59.6M | |
Capital Stock | 43.9K | 45.0K | 49.0K | 49.0K | 56.4K | 51.0K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MediciNova Stock Analysis
When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.